Medications for High Cholesterol, Familial Homozygous
Other names: Familial Hypercholesterolemia, Homozygous; Homozygous Familial Hypercholesterolemia; Homozygous FH; Hypercholesterolemia, Familial Homozygous
What is High Cholesterol, Familial Homozygous: High cholesterol is the presence of high levels of cholesterol in the blood. Familial means that is passed down through families and is a genetic disorder. The altered gene that causes familial high cholesterol is located on chromosome number 19. It contains the information for… Read more
Medications to treat High Cholesterol, Familial Homozygous
The following list of medications are in some way related to, or used in the treatment of this condition.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| Crestor | Rx | X | N | Add review | |||
|
Generic name: rosuvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
| Lipitor | Rx | X | N | 2 reviews | |||
|
Generic name: atorvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
| simvastatin | Rx | X | N | Add review | |||
|
Generic name: simvastatin systemic Brand name: Zocor Drug class: statins For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
| atorvastatin | Rx | X | N | 3 reviews | |||
|
Generic name: atorvastatin systemic Brand name: Lipitor Drug class: statins For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
| Vytorin | Rx | X | N | Add review | |||
|
Generic name: ezetimibe / simvastatin systemic Drug class: antihyperlipidemic combinations For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
| Zocor | Rx | X | N | Add review | |||
|
Generic name: simvastatin systemic Drug class: statins For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
| Juxtapid | Rx | X | N | X | Add review | Add | |
|
Generic name: lomitapide systemic Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
| rosuvastatin | Rx | X | N | Add review | |||
|
Generic name: rosuvastatin systemic Brand name: Crestor Drug class: statins For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph, Prescribing Information |
|||||||
| Kynamro | Rx | B | N | X | Add review | Add | |
|
Generic name: mipomersen systemic Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
| ezetimibe / simvastatin | Rx | X | N | Add review | |||
|
Generic name: ezetimibe / simvastatin systemic Brand name: Vytorin Drug class: antihyperlipidemic combinations For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, Prescribing Information |
|||||||
| Repatha | Rx | N | 3 reviews | ||||
|
Generic name: evolocumab systemic Drug class: PCSK9 inhibitors For consumers: dosage, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
| lomitapide | Rx | X | N | X | Add review | Add | |
|
Generic name: lomitapide systemic Brand name: Juxtapid Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
| mipomersen | Rx | B | N | X | Add review | Add | |
|
Generic name: mipomersen systemic Brand name: Kynamro Drug class: miscellaneous antihyperlipidemic agents For consumers: dosage, interactions, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
| Praluent | Rx | N | 2 reviews | ||||
|
Generic name: alirocumab systemic Drug class: PCSK9 inhibitors For consumers: dosage, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
| alirocumab | Rx | N | 2 reviews | ||||
|
Generic name: alirocumab systemic Brand name: Praluent Drug class: PCSK9 inhibitors For consumers: dosage, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
| evolocumab | Rx | N | 3 reviews | ||||
|
Generic name: evolocumab systemic Brand names: Repatha, Repatha Pushtronex Drug class: PCSK9 inhibitors For consumers: dosage, side effects For professionals: A-Z Drug Facts, AHFS DI Monograph |
|||||||
| Repatha Pushtronex | Rx | N | Add review | Add | |||
|
Generic name: evolocumab systemic Drug class: PCSK9 inhibitors For consumers: dosage, side effects |
|||||||
Learn more about High Cholesterol, Familial Homozygous
Drugs.com Health Center
Legend
| Off Label | This medication may not be approved by the FDA for the treatment of this condition. |
| Prescription Only / Over the Counter | |
|---|---|
| Rx | Prescription Only |
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over the Counter |
| Pregnancy | |
|---|---|
| A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
| N | FDA has not classified the drug. |
| Controlled Substances Act Schedule | |
|---|---|
| N | Is not subject to the Controlled Substances Act. |
| 1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
| 2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
| 3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |